Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - Hoshi, Tomoya; Sato, Akira; Nogami, Akihiko; Gosho, Masahiko; Aonuma, Kazutaka (Journal of cardiology, 2017)
Keywords: Apixaban; Aspirin - administration & dosage; Atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - therapy; Blood Transfusion; Cardiovascular; Drug Therapy, Combination; Drug-eluting stent; Drug-Eluting Stents; Factor Xa Inhibitors - administration & dosage; Female; Hemorrhage - chemically induced; Hemorrhage - prevention & control; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors - administration & dosage; Prasugrel Hydrochloride - administration & dosage; Prospective Studies; Purinergic P2Y Receptor Antagonists - administration & dosage; Pyrazoles - administration & dosage; Pyridones - administration & dosage; Stroke - prevention & control; Ticlopidine - administration & dosage; Ticlopidine - analogs & derivatives; Triple therapy; Triple therapy; Atrial fibrillation; Drug-eluting stent; Apixaban